Biotech ContraFect Announces Independent DSMB Recommends Exebacase Phase 3 DISRUPT Study Be Stopped for Futility Following Interim Analysis July 13, 2022
Biotech Wall Street Analysts Think Anavex Life Sciences (AVXL) Could Surge 179%: Read This Before Placing a Bet July 13, 2022
Biotech Oncocyte Announces Market Entry and Early Adopter Program for Transplant Rejection Monitoring Business July 13, 2022
Biotech Genprex to Participate in Next Generation Lipid-Based Nanoparticles Delivery Summit July 13, 2022
Biotech Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split July 12, 2022